T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$6.08B |
| 2 |
PayPal
PYPL
|
+$722M |
| 3 |
JNPR
Juniper Networks
JNPR
|
+$712M |
| 4 |
FITB
Fifth Third Bancorp
FITB
|
+$692M |
| 5 |
Morgan Stanley
MS
|
+$644M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$5.54B |
| 2 |
Vipshop
VIPS
|
+$825M |
| 3 |
Honeywell
HON
|
+$813M |
| 4 |
Estee Lauder
EL
|
+$804M |
| 5 |
GE Aerospace
GE
|
+$787M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.49% |
| 2 | Consumer Discretionary | 15.06% |
| 3 | Financials | 13.94% |
| 4 | Technology | 11.82% |
| 5 | Industrials | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
NovoCure
NVCR
$2.05B
| $55.7M | 0.01% |
+2,588,825
| New | +$61.8M |
|
|
TGI
727
DELISTED
Triumph Group
TGI
| $55.7M | 0.01% |
1,401,688
+1,387,188
| +9,567% | +$56M |
|
|
CLVS
728
DELISTED
Clovis Oncology, Inc.
CLVS
| $55.4M | 0.01% |
1,582,895
-353,978
| -18% | -$22.8M |
|
|
GAP
729
The Gap Inc
GAP
$7.29B
| $55.3M | 0.01% |
2,239,815
+1,669,750
| +293% | +$44.5M |
|
730
QuidelOrtho
QDEL
$1.02B
| $55.1M | 0.01% |
2,597,622
-73,918
| -3% | -$1.5M |
|
731
eBay
EBAY
$45.5B
| $54.8M | 0.01% |
1,993,097
-113,500
| -5% | -$3.13M |
|
732
Exponent
EXPO
$3.22B
| $54.7M | 0.01% |
2,191,216
+86,780
| +4% | +$2.2M |
|
733
Wheaton Precious Metals
WPM
$61.3B
| $54.7M | 0.01% |
4,400,916
-3,370,050
| -43% | -$44.5M |
|
|
TNGO
734
DELISTED
Tangoe, Inc.
TNGO
| $54.5M | 0.01% |
6,496,110
+26,260
| +0.4% | +$211K |
|
|
MDCO
735
DELISTED
Medicines Co
MDCO
| $54.4M | 0.01% |
1,457,570
-1,500
| -0.1% | -$56.7K |
|
736
Murphy USA
MUSA
$10.1B
| $54.4M | 0.01% |
895,491
+3,993
| +0.4% | +$239K |
|
737
HDFC Bank
HDB
$119B
| $54.1M | 0.01% |
3,511,888
+55,180
| +2% | +$834K |
|
738
PennyMac Financial
PFSI
$4B
| $53.9M | 0.01% |
3,510,350
+1,439,140
| +69% | +$23.3M |
|
739
Norfolk Southern
NSC
$75.3B
| $53.9M | 0.01% |
636,818
-19,789
| -3% | -$1.69M |
|
|
ININ
740
DELISTED
Interactive Intelligence Group, inc.
ININ
| $53.8M | 0.01% |
1,712,984
-193,020
| -10% | -$6.27M |
|
741
Cavco Industries
CVCO
$4.6B
| $53.6M | 0.01% |
642,950
-54,470
| -8% | -$4.63M |
|
742
Viavi Solutions
VIAV
$10.6B
| $53.3M | 0.01% |
8,756,357
-403,979
| -4% | -$2.45M |
|
743
Jazz Pharmaceuticals
JAZZ
$16.2B
| $53.2M | 0.01% |
378,564
-9,673
| -2% | -$1.34M |
|
|
IRBT
744
DELISTED
iRobot
IRBT
| $53M | 0.01% |
1,498,580
-10,420
| -0.7% | -$337K |
|
|
VIVO
745
DELISTED
Meridian Bioscience Inc
VIVO
| $53M | 0.01% |
2,583,155
+47,070
| +2% | +$902K |
|
746
Artisan Partners
APAM
$2.97B
| $52.9M | 0.01% |
1,465,638
-270,192
| -16% | -$9.98M |
|
|
ANDV
747
DELISTED
Andeavor
ANDV
| $52.4M | 0.01% |
497,153
+39,500
| +9% | +$4.26M |
|
|
BUFF
748
DELISTED
Blue Buffalo Pet Products, Inc
BUFF
| $52.2M | 0.01% |
2,790,538
+524,338
| +23% | +$9.58M |
|
749
Autohome
ATHM
$2.65B
| $52.2M | 0.01% |
1,495,131
+825,565
| +123% | +$27.8M |
|
|
EBSB
750
DELISTED
Meridian Bancorp, Inc.
EBSB
| $52.2M | 0.01% |
3,699,670
-116,050
| -3% | -$1.65M |
|
Similar funds
T. Rowe Price Associates's Q4 2015 Portfolio in Review
As of Q4 2015, T. Rowe Price Associates held 2,616 positions worth $475B, up 5.8% from $449B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q4 2015 filing shows 108 new, 1,286 increased, 995 reduced and 102 closed positions. Its largest new stake was Alphabet (Google) Class A: 164,207,340 shares worth $6.39B. The largest sale was Alphabet (Google) Class C, an estimated $5.54B.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q4 2015 buy was Alphabet (Google) Class A: 164,207,340 shares worth $6.39B.
- T. Rowe Price Associates added most to PayPal in Q4 2015, an estimated $722M increase.
- T. Rowe Price Associates's biggest Q4 2015 reduction was Alphabet (Google) Class C, cutting an estimated $5.54B.
- T. Rowe Price Associates fully exited CYTEC INDS INC in Q4 2015, selling an estimated $610M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $475B portfolio in Q4 2015.
- T. Rowe Price Associates opened 108 new positions and closed 102 in Q4 2015.
- T. Rowe Price Associates's portfolio value rose 5.8% quarter-over-quarter to $475B.
Based on T. Rowe Price Associates's 13F filing for Q4 2015, filed 16 Feb 2016.